Vessi Medical, a portfolio company of The Trendlines Group announced that it secured $1.7 million in funding for its cryoablation solution for superficial bladder cancer. Participating in the financing were Agriline, The Trendlines Group, the Israel Innovation Authority, and ExitValley investors. Vessi’s first-in-human (FIH) study demonstrating safety and efficacy of the Vessi intravesical cryotherapy device […]

Trendlines Labs Singapore will invent and develop novel medical technologies, innovating and creating value for Trendlines’ portfolio companies and strategic partners

CE marking in the EU and a new partnership with Genesis Biologics in the US.

ElastiMed has developed a wearable medical product designed to increase blood flow to the legs and treat edema and venous insufficiency. This product can improve the quality of life of millions of people around the world. ElastiMed is now completing an investment round on ExitValley.

Vessi Medical has developed an innovative medical device that eliminates bladder cancer cells using advanced cell freezing technology, without compromising the patient’s quality of life. Vessi is now completing an investment round on ExitValley.

The Trendlines Group announced the 100% acquisition of portfolio company ApiFix, a company focused on non-fusion treatment of progressive adolescent idiopathic scoliosis, by OrthoPediatrics

OrthoSpin has completed a US $5 million in a series B financing for its robotic, digitally enabled external fixation system for orthopedic treatments. Johnson & Johnson Innovation (JJDC), led the investment round together with Trendlines.

OrthoSpin’s external fixation system featured in Israeli media, Arutz Sheva.

Leviticus-Cardio named one of best medical technologies of 2019 by Medgadget.

OrthoSpin’s external fixation system appeared in Paula & Leon Keshet TV, Breaking News Israel and ynet.